We’re proud to share that some partners from the IMVACS consortium will take part in the upcoming MSF Scientific Day on 20th May in London.

An abstract submitted by the team has been accepted for an oral presentation, highlighting important research on:
“Delivery R21 vaccine through seasonal malaria chemoprevention: coverage and qualitative insights from cluster-randomised trials in Burkina Faso, Mali and Chad.”

The presentation will be delivered by Dr. Lise Denoeud (Epicentre/Médecins Sans Frontières) and Jenna Hoyt (Liverpool School of Tropical Medicine), showcasing valuable findings that contribute to advancing malaria prevention strategies in high-burden settings.

This is a great opportunity to engage with cutting-edge research and connect with experts working at the forefront of global health.

👉 To register for the event, visit: https://registration.msfscientificdays2026.org.uk/msfsdi26/register